BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gomez D, Patel P, Lacasia-purroy C, Byrne C, Sturgess R, Palmer D, Fenwick S, Poston G, Malik H. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma. European Journal of Surgical Oncology (EJSO) 2014;40:77-84. [DOI: 10.1016/j.ejso.2013.10.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Ratti F, Cipriani F, Piozzi G, Catena M, Paganelli M, Aldrighetti L. Comparative Analysis of Left- Versus Right-sided Resection in Klatskin Tumor Surgery: can Lesion Side be Considered a Prognostic Factor? J Gastrointest Surg 2015;19:1324-33. [DOI: 10.1007/s11605-015-2840-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
2 Coelen RJ, Ruys AT, Besselink MG, Busch OR, van Gulik TM. Diagnostic accuracy of staging laparoscopy for detecting metastasized or locally advanced perihilar cholangiocarcinoma: a systematic review and meta-analysis. Surg Endosc 2016;30:4163-73. [PMID: 26895909 DOI: 10.1007/s00464-016-4788-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
3 Ratti F, Cipriani F, Fiorentini G, Hidalgo Salinas C, Catena M, Paganelli M, Aldrighetti L. Management of hilum infiltrating tumors of the liver: The impact of experience and standardization on outcome. Dig Liver Dis. 2019;51:135-141. [PMID: 30115572 DOI: 10.1016/j.dld.2018.07.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
4 Ke Q, Chen Y, Huang Q, Lin N, Wang L, Liu J. Does additional resection of a positive microscopic ductal margin benefit patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis. PLoS One 2020;15:e0232590. [PMID: 32379819 DOI: 10.1371/journal.pone.0232590] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Stremitzer S, Jones RP, Quinn LM, Fenwick SW, Diaz-Nieto R, Poston GJ, Malik HZ. Clinical outcome after resection of early-stage hilar cholangiocarcinoma. Eur J Surg Oncol. 2019;45:213-217. [PMID: 30360988 DOI: 10.1016/j.ejso.2018.09.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
6 Mantel HT, Westerkamp AC, Adam R, Bennet WF, Seehofer D, Settmacher U, Sánchez-Bueno F, Fabregat Prous J, Boleslawski E, Friman S, Porte RJ; European Liver and Intestine Transplant Association (ELITA). Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival. PLoS One 2016;11:e0156127. [PMID: 27276221 DOI: 10.1371/journal.pone.0156127] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 5.7] [Reference Citation Analysis]
7 Quinn LM, Dunne DFJ, Jones RP, Poston GJ, Malik HZ, Fenwick SW. Optimal perioperative care in peri-hilar cholangiocarcinoma resection. Eur Surg 2018;50:93-9. [PMID: 29875797 DOI: 10.1007/s10353-018-0529-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Cholangiocarcinoma Working Group. Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment. Dig Liver Dis 2020;52:1430-42. [PMID: 32952071 DOI: 10.1016/j.dld.2020.08.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
9 She WH, Cheung TT, Ma KW, Yin Tsang SH, Dai WC, Yan Chan AC, Lo CM. Impact of preoperative biliary drainage on postoperative outcomes in hilar cholangiocarcinoma. Asian J Surg 2021:S1015-9584(21)00560-1. [PMID: 34588138 DOI: 10.1016/j.asjsur.2021.07.075] [Reference Citation Analysis]
10 Niederwieser T, Braunwarth E, Dasari BVM, Pufal K, Szatmary P, Hackl H, Haselmann C, Connolly CE, Cardini B, Öfner D, Roberts K, Malik H, Stättner S, Primavesi F. Early postoperative arterial lactate concentrations to stratify risk of post-hepatectomy liver failure. Br J Surg 2021;108:1360-70. [PMID: 34694377 DOI: 10.1093/bjs/znab338] [Reference Citation Analysis]
11 Bird N, Elmasry M, Jones R, Elniel M, Kelly M, Palmer D, Fenwick S, Poston G, Malik H. Role of staging laparoscopy in the stratification of patients with perihilar cholangiocarcinoma. Br J Surg 2017;104:418-25. [PMID: 27861766 DOI: 10.1002/bjs.10399] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
12 Coelen RJ, Ruys AT, Wiggers JK, Nio CY, Verheij J, Gouma DJ, Besselink MG, Busch OR, van Gulik TM. Development of a Risk Score to Predict Detection of Metastasized or Locally Advanced Perihilar Cholangiocarcinoma at Staging Laparoscopy. Ann Surg Oncol. 2016;23:904-910. [PMID: 27586005 DOI: 10.1245/s10434-016-5531-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
13 Alabraba E, Joshi H, Bird N, Griffin R, Sturgess R, Stern N, Sieberhagen C, Cross T, Camenzuli A, Davis R, Evans J, O'grady E, Palmer D, Diaz-nieto R, Fenwick S, Poston G, Malik H. Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged. European Journal of Surgical Oncology 2019;45:1660-7. [DOI: 10.1016/j.ejso.2019.04.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Coelen RJ, Wiggers JK, Nio CY, Besselink MG, Busch OR, Gouma DJ, van Gulik TM. Preoperative computed tomography assessment of skeletal muscle mass is valuable in predicting outcomes following hepatectomy for perihilar cholangiocarcinoma. HPB (Oxford) 2015;17:520-8. [PMID: 25726722 DOI: 10.1111/hpb.12394] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
15 Bird N, McKenna A, Dunne D, Francis B, Fenwick S, Poston G, Jones R, Malik H. Role of a pre-operative radiological scoring system in determining resectability for potentially resectable hilar cholangiocarcinoma. Eur J Surg Oncol 2019;45:192-7. [PMID: 30297275 DOI: 10.1016/j.ejso.2018.08.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Stremitzer S, Stift J, Laengle J, Schwarz C, Kaczirek K, Jones RP, Quinn LM, Fenwick SW, Diaz-Nieto R, Poston GJ, Malik HZ. Prognosis and Circumferential Margin in Patients with Resected Hilar Cholangiocarcinoma. Ann Surg Oncol 2021;28:1493-8. [PMID: 32914390 DOI: 10.1245/s10434-020-09105-1] [Reference Citation Analysis]
17 Matsuyama R, Morioka D, Mori R, Yabushita Y, Hiratani S, Ota Y, Kumamoto T, Endo I. Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for "Borderline Resectable" in the Field of Surgery for Hilar Cholangiocarcinoma. World J Surg 2019;43:1094-104. [PMID: 30536024 DOI: 10.1007/s00268-018-04883-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]